APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.

HELSINKI, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Aplagon, a clinical stage biopharmaceutical company developing a first-in-class therapeutic for thrombo-inflammatory diseases, known as APAC ...

Holt joins DigiCert from Venafi, where he served as Vice President of Sales, covering both the EMEA and APAC markets. With decades of experience, Holt has also held senior leadership positions at ...

Financing led by new Investors Fåhraeus Startup and Growth and EIC FundHELSINKI, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Aplagon, a ...